Clinical Trial

Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis
Trial Details
NCT Number NCT04704947
Lead Sponsor Sherief Abd-Elsalam
Conditions Beta Blocker Toxicity
Enrollment 50 participants
Start Date 2017-10-01
Primary Completion 2030-10-01 (estimated)
Study Completion 2030-10-01 (estimated)
Updated on ClinicalTrials.gov 2021-01-12